Open-House Discount Agreement for Abaloparatid
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2026-01 - Abaloparatid
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
25 / 100
Risk factors
No estimated contract value provided. The financial opportunity cannot be assessed.
Submission must be via email with qualified electronic signature or postal mail with scan. Not using standard e-procure...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Feb 2028
- Supply of pharmaceutical products containing Abaloparatid to German statutory health insurance funds.
- Conclusion of discount agreements under § 130c SGB V with uniform conditions.
Show full summary
Open-house procedure for discount agreements (Rabattverträge) for the active substance Abaloparatid under § 130c SGB V. The contracting authority is Techniker Krankenkasse (TK) together with HEK and hkk. This is not a standard public procurement but an open-house model where any eligible pharmaceutical entrepreneur can join during the contract term. The contract runs from 01.03.2026 to 29.02.2028 (max 24 months). No estimated value is provided. Participation is limited to pharmaceutical entrepreneurs with a valid marketing authorization for Abaloparatid. Submission is via email or post, not through the e-procurement portal.
Risks
No estimated contract value provided. The financial opportunity cannot be assessed.
Submission must be via email with qualified electronic signature or postal mail with scan. Not using standard e-procure...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG.
- Must have a valid marketing authorization for the medicinal product containing Abaloparatid.
- Must be established in Germany, EU, or EEA.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open-House Discount Agreement for Abaloparatid
Conclusion of discount agreements for the active substance Abaloparatid under § 130c SGB V. Open-house procedure with no exclusivity. Any pharmaceutical entrepreneur meeting eligibility criteria may join at any time during the contract term.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria specified. The open-house procedure implies that any eligible participant is accepted without competitive award.
Value note
Show original TED data
Original lot title
Open-House-Biologika-Rabattverträge 2026-01 - Abaloparatid
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Abaloparatid im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 27 Jan 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 62082-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
25 / 100
Risk factors
No estimated contract value provided. The financial opportunity cannot be assessed.
Submission must be via email with qualified electronic signature or postal mail with scan. Not using standard e-procure...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications